JESSICA VINCENT: Open Payments
NPI 1023385275 · MCMINNVILLE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$244 in 15 payments from 8 companies in 2025. Trend: 2023 $592 · 2024 $437 · 2025 $244
Food & beverage: $244
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $82 |
| Novo Nordisk Inc | 3 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| Exact Sciences Corporation | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
| ABBVIE INC. | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
| Organon LLC | 1 | $4 |
Products named: EVENITY, Ozempic, COBENFY, The Cologuard Plus Collection Kit, JARDIANCE, QULIPTA, ZENPEP, NEXPLANON.
Industry payments across OR — which companies pay providers there.
